BiotechTube

Furosemide

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pre-Eclampsia

Conditions

Pre-Eclampsia, Hypertension in Pregnancy, Pregnancy Complications, Hypertension, Pregnancy-Induced

Trial Timeline

Jan 4, 2021 → Apr 29, 2022

NCT ID
NCT04615624

About Furosemide

Furosemide is a phase 3 stage product being developed by Pacific Biosciences for Pre-Eclampsia. The current trial status is completed. This product is registered under clinical trial identifier NCT04615624. Target conditions include Pre-Eclampsia, Hypertension in Pregnancy, Pregnancy Complications.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT04615624Phase 3Completed

Competing Products

3 competing products in Pre-Eclampsia

See all competitors
ProductCompanyStageHype Score
Placebo + RLX030NovartisPhase 2
52
recombinant human relaxinNovartisPhase 1
33
Sildenafil citratePfizerPhase 2
51

Other Products from Pacific Biosciences

pantoprazole + bismuth + metronidazole + tetracyclineApproved
77
EmtricitabineApproved
77
A single oral 5 mg of duterium labeled methamphetamineApproved
77
RamiprilApproved
77
Emtricitabine plus adefovir dipivoxilApproved
77